Overexpression of non-functional LAT1/4F2hc in renal proximal tubular epithelial cells from the spontaneous hypertensive rat

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 535-548

  Pinho, Maria João ^a   Serrão, Maria Paula ^a   Jose, Pedro A ^b   Soares Da Silva, Patrício ^a,c  

^a Institute of Pharmacology and Therapeutics   (Portugal)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

4F2hc; Hypertension; L leucine; LAT1; Sodium

Indexed keywords

2 AMINOBICYCLO(2,2,1) HEPTANE 2 CARBOXYLIC ACID; 4F2HC PROTEIN; ALANYLALANYLTHREONYLALANYLTHREONYLCYSTEINYLALANYLCYSTEINYLAL ANYLCYSTEINYLTHREONYLGLYCYLALANYLTHREONYLCYSTEINYLALANYLALANYLTHREONYL GLYCYLGLYCYLTHREONYLCYSTEINE; AMINO ACID TRANSPORTER; AMINO ACID TRANSPORTER TYPE 1; CARBOXYLIC ACID DERIVATIVE; GLYCOPROTEIN; LEUCINE C 14; RADIOISOTOPE; SMALL INTERFERING RNA; SODIUM; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL IMMORTALIZATION; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; EPITHELIUM CELL; EXTRACELLULAR FLUID; GENE EXPRESSION; GENE SILENCING; HYPERTENSION; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

RATTUS;

EID: 34548369605     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107537     Document Type: Article

References (31)

1. Pinho MJ, Gomes P, Serrao MP, Bonifacio MJ, Soares-da-Silva P: Organ-specific overexpression of renal LAT2 and enhanced tubular L-DOPA uptake precede the onset of hypertension. Hypertension 2003;42:613-618.
2. Lucas-Teixeira VA, Vieira-Coelho MA, Serrao P, Pestana M, Soares-da-Silva P: Salt intake and sensitivity of intestinal and renal Na+-K+ atpase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin Exp Hypertens 2000;22:455-469.
3. 0,+ , exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J Membr Biol 2002;186:63-80.
4. 1 renal cells. Am J Physiol Renal Physiol 2004;287:F252-F261.
5. Quinones H, Collazo R, Moe OW: The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol 2004;287:F74-F80.
6. 1 epithelial cells. Faseb J 2004;18:1489-1498.
7. Pinho MJ, Serrao MP, Gomes P, Hopfer U, Jose PA, Soares-da-Silva P: Overexpression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells. Kidney Int 2004;66:216-226.
8. Palacin M, Estevez R, Bertran J, Zorzano A: Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998;78:969-1054.
9. Kanai Y, Endou H: Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2001;2:339-354.
10. Prasad PD, Wang H, Huang W, Kekuda R, Rajan DP, Leibach FH, Ganapathy V: Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 1999;255:283-288.
11. + -independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999;274:19745-19751.
12. Wagner CA, Lang F, Broer S: Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 2001;281:C1077-C1093.
13. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y: CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 2004;447:532-542.
14. Pinto-do-Ó PC, Soares-da-Silva P: Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br J Pharmacol 1996;118:741-747.
15. Pedrosa R, Gomes P, Zeng C, Hopfer U, Jose PA, Soares-da-Silva P: Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol 2004;142:1343-1353.
16. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG, Hopfer U: Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int 1996;50:125-134.
17. Morderelle A, Jullian E, Costa C, Cormet-Boyaka E, Benamouzig R, Tomé D, Huneau JF: EAAT1 is involved in transport of L-glutamate during differentiation of the Caco-2 cell line. Am J Physiol Gastrointest Liver Physiol 2000;279:G366-G373.
18. DeBlasi A, O'Reilly K, Motulsky HJ: Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 1989;10:227-229.
19. Motulsky HJ: Analyzing Data with GraphPad Prism, Version 3.0 ed. GraphPad Prism Software, Inc., San Diego, CA 1999.
20. Broer A, Klingel K, Kowalczuk S, Rasko JE, Cavanaugh J, Broer S: Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder. J Biol Chem 2004;279:24467-24476.
21. Kanai Y, Fukasawa Y, Cha SH, Segawa H, Chairoungdua A, Kim DK, Matsuo H, Kim JY, Miyamoto K, Takeda E, Endou H: Transport properties of a system y+L neutral and basic amino acid transporter. Insights into the mechanisms of substrate recognition. J Biol Chem 2000;275:20787-20793.
22. + L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. Embo J 1999;18:49-57.
23. + L. A candidate gene for lysinuric protein intolerance. J Biol Chem 1998;273:32437-32445.
24. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H: Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998;273:23629-23632.
25. Verrey F: System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003;445:529-533.
26. Kudo Y, Boyd CA: RNA interference-induced reduction in CD98 expression suppresses cell fusion during syncytialization of human placental BeWo cells. FEBS Lett 2004;577:473-477.
27. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM: Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A 1999;96:12079-12084.
28. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T, Endou H: Human Ltype amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001;1514:291-302.
29. Racz K, Kuchel O, Buu NT, Tenneson S: Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res 1985;57:889-897.
30. Sanada H, Watanabe H, Shigetomi S, Fukuchi S: Gene expression of aromatic L-amino acid decarboxylase mRNA in the kidney of normotensive and hypertensive rats. Hypertens Res 1995;18 Suppl 1:S179-181.
31. Yoshimura M, Ikegaki I, Nishimura M, Takahashi H: Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension. J Auton Pharmacol 1990;10 Suppl 1:s67-72.